Clinical, laboratory and imaging characteristics of severe and critical COVID-19 patients at Dong Da General Hospital in 2022

ABSTRACT

Objective: To describe the clinical and paraclinical characteristics of severe and critical COVID-19 patients at Dong Da General Hospital in 2022.

Participants and Methods: A retrospective study was conducted on 294 severe and critical COVID-19 patients treated from January to December 2022.

Results: The most common symptoms were fatigue (81%), dyspnea (76.5%), and fever (74.5%); 85.7% of patients were admitted to the hospital within 3 days of symptom onset. Paraclinical findings included leukocytosis (29.3%), neutrophilia (47.6%), lymphopenia (51.0%), anemia (13.3%), and decreased prothrombin ratio (83.7%). Elevated biochemical indices were observed, including urea (35.4%), creatinine (19.0%), LDH (34.0%), ferritin (47.6%), CRP (55.8%), AST (42.2%), and ALT (23.5%).

Conclusion: The study highlights the clinical and paraclinical characteristics of severe and critical COVID-19 patients, which can aid in the early identification and management of high-risk cases.

Keywords: Severe COVID-19, critical COVID-19

File toàn văn

Bài báo liên quan

• Prognostic factors for early mortality in patients with septic shock at the National Hospital for Tropical Diseases from 2017-2022
• Survival outcomes of antiretroviral therapy in HIV/AIDS patients at Bach Mai Hospital from 2009-2021
• The prognostic value of the 4C Mortality Score in predicting mortality in severe and critical COVID-19 patients hospitalized within 24 hours at the Intensive Care Unit 1, Center for COVID-19 Critical Care and Treatment, Bach Mai Hospital
• Clinical, laboratory and imaging characteristics of severe and critical COVID-19 patients at Dong Da General Hospital in 2022
• Clinical, laboratory and imaging features of adult tuberculous meningitis at Bach Mai Hospital
• A Case report of Methicillin-resistant Staphylococcus aureus meningitis and brain abscess following Dengue fever
• Pyodermatous skin lesions: A rare case of extra-intestinal manifestation of inflammatory bowel disease
• Challenges and advances in the diagnosis of invasive Mucormycosis